RET and neoplasm: Mutations in the EIF1AX gene have been detected in tumours that typically be deficient in other common drivers and identified in 1.5% of The Cancer Genome Atlas (TCGA) cohort, which are indicating that EIF1AX gene may play a role a novel PTC oncogene (33).